The GTPase-activating protein n-chimaerin cooperates with Rac1 and Cdc42Hs to induce the formation of lamellipodia and filopodia - PubMed (original) (raw)

The GTPase-activating protein n-chimaerin cooperates with Rac1 and Cdc42Hs to induce the formation of lamellipodia and filopodia

R Kozma et al. Mol Cell Biol. 1996 Sep.

Abstract

n-Chimaerin is a GTPase-activating protein (GAP) mainly for Rac1 and less so for Cdc42Hs in vitro. The GAP activity of n-chimaerin is regulated by phospholipids and phorbol esters. Microinjection of Rac1 and Cdc42Hs into mammalian cells induces formation of the actin-based structures lamellipodia and filopodia, respectively, with the former being prevented by coinjection of the chimaerin GAP domain. Strikingly, microinjection of the full-length n-chimaerin into fibroblasts and neuroblastoma cells induces the simultaneous formation of lamellipodia and filopodia. These structures undergo cycles of dissolution and formation, resembling natural morphological events occurring at the leading edge of fibroblasts and neuronal growth cones. The effects of n-chimaerin on formation of lamellipodia and filopodia were inhibited by dominant negative Rac1(T17N) and Cdc42Hs(T17N), respectively. n-Chimaerin's effects were also inhibited by coinjection with Rho GDP dissociation inhibitor or by treatment with phorbol ester. A mutant n-chimaerin with no GAP activity and impaired p21 binding was ineffective in inducing morphological changes, while a mutant lacking GAP activity alone was effective. Microinjected n-chimaerin colocalized in situ with F-actin. Taken together, these results suggest that n-chimaerin acts synergistically with Rac1 and Cdc42Hs to induce actin-based morphological changes and that this action involves Rac1 and Cdc42Hs binding but not GAP activity. Thus, GAPs may have morphological functions in addition to downregulation of GTPases.

PubMed Disclaimer

Cited by

Rho/ROCK pathway and neural regeneration: a potential therapeutic target for central nervous system and optic nerve damage.
Tan HB, Zhong YS, Cheng Y, Shen X. Tan HB, et al. Int J Ophthalmol. 2011;4(6):652-7. doi: 10.3980/j.issn.2222-3959.2011.06.16. Epub 2011 Dec 18. Int J Ophthalmol. 2011. PMID: 22553739 Free PMC article.
Requirements for both Rac1 and Cdc42 in membrane ruffling and phagocytosis in leukocytes.
Cox D, Chang P, Zhang Q, Reddy PG, Bokoch GM, Greenberg S. Cox D, et al. J Exp Med. 1997 Nov 3;186(9):1487-94. doi: 10.1084/jem.186.9.1487. J Exp Med. 1997. PMID: 9348306 Free PMC article.
A novel group of multi-GAP-domain proteins.
Ruan Y, Sensen CW, van der Hoorn FA. Ruan Y, et al. Mol Reprod Dev. 2008 Oct;75(10):1578-89. doi: 10.1002/mrd.20896. Mol Reprod Dev. 2008. PMID: 18363199 Free PMC article.
Semaphorin 5A and plexin-B3 inhibit human glioma cell motility through RhoGDIalpha-mediated inactivation of Rac1 GTPase.
Li X, Lee AY. Li X, et al. J Biol Chem. 2010 Oct 15;285(42):32436-45. doi: 10.1074/jbc.M110.120451. Epub 2010 Aug 9. J Biol Chem. 2010. PMID: 20696765 Free PMC article.
TCGAP, a multidomain Rho GTPase-activating protein involved in insulin-stimulated glucose transport.
Chiang SH, Hwang J, Legendre M, Zhang M, Kimura A, Saltiel AR. Chiang SH, et al. EMBO J. 2003 Jun 2;22(11):2679-91. doi: 10.1093/emboj/cdg262. EMBO J. 2003. PMID: 12773384 Free PMC article.

References

1. Annu Rev Cell Biol. 1988;4:487-525 - PubMed
1. Methods Enzymol. 1995;256:114-25 - PubMed
1. Mol Cell Biol. 1989 Mar;9(3):946-58 - PubMed
1. Cell. 1989 Oct 6;59(1):45-54 - PubMed
1. Br Med Bull. 1989 Apr;45(2):515-28 - PubMed

The GTPase-activating protein n-chimaerin cooperates with Rac1 and Cdc42Hs to induce the formation of lamellipodia and filopodia - PubMed (original) (raw)